Two Sigma Advisers’s VIVEVE MED INC VIVE Stock Holding History

Two Sigma Advisers’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,300	Closed	-$24K	–	2965
2022 Q1	$24K	Sell	22,300 -2,000	-8%	-$2K	﹤0.01%	2658
2021 Q4	$28K	Buy	+24,300	New	+$44.6K	﹤0.01%	2529

Other funds holding VIVE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Two Sigma Advisers's VIVE Position: Q2 2022 in Review

Two Sigma Advisers sold out of VIVEVE MED INC (VIVE) in Q2 2022, closing a stake of 22,300 shares — an estimated $24K sold.

Two Sigma Advisers first reported a position in VIVE in Q4 2021 and held it in 2 quarters. The position peaked at $28K in Q4 2021. 20 funds tracked by Wall St. Rank hold VIVE as of Q2 2022.

Two Sigma Advisers reported no remaining VIVEVE MED INC position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 22,300 VIVEVE MED INC shares in Q2 2022, an estimated $24K.
Two Sigma Advisers first reported a position in VIVEVE MED INC in Q4 2021 and held it in 2 quarters.
Two Sigma Advisers's VIVEVE MED INC position peaked at $28K in Q4 2021.
20 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.